Emrusolmin is expected to improve symptoms of MSA by targeting alpha synuclein oligomers. The Food and Drug Administration (FDA) has granted Fast Track designation to emrusolmin (TEV-56286) for the ...
ROCK ISLAND ARSENAL, Illinois (Sept. 9, 2025) – Army Contracting Command-Rock Island’s Source Selection Support Center of Excellence (S3COE) team, which consists of Jacob Harrison, lead procurement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results